Deal Watch: Lilly Takes Global Rights To Centrexion Non-Opioid Pain Candidate

 
• By Joseph Haas and Eleanor Malone
  
DealWatch_1200x675
New deals by Lilly and Viela lead this edition of Deal Watch
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business